Insider Profile
Smith, Eldon
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Feb 22, 2021
Most Recent Trade
1
Credibility
Score
Score
0%
Hit Rate
-10.5%
Avg 90d Return
-0.3%
Median 90d Return
3
Evaluated Trades
-0.3%
Best Trade
-30.9%
Worst Trade
Hit rate and returns are based on 3 open-market buys with evaluable
90-day outcomes. Score reflects historical conviction, not a guarantee of future performance.
Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
100%
Hit Rate · 90d
+6.4%
Median Alpha · 90d
2
Closed Buys Evaluated
100%
Beat XIU
All-insider base rate:
59% hit rate
· +1.3% mean alpha
(n=11504)
cluster buyer
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later.
Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research
2 closed buys with individual return outcomes available on the
Research plan.
| Date | Company | Dir. | Value |
|---|---|---|---|
| Feb 22, 2021 |
$CRDL
Cardiol Therapeutics Inc
|
Sell | $32K |
| Feb 22, 2021 |
$CRDL
Cardiol Therapeutics Inc
|
Buy | $32K |
| Jun 04, 2020 |
$CRDL
Cardiol Therapeutics Inc
|
Buy | $2K |
| Jun 04, 2020 |
$CRDL
Cardiol Therapeutics Inc
|
Buy | $48K |
Muted rows are plan purchases, compensation grants, or DRIP — not open-market.
Confluence Scores reflect the company's current score, not the score at time of trade.